
6th September 2019 AI creates new drug compounds in 21 days Insilico Medicine reports the creation, via artifical intelligence, of six novel inhibitors of the DDR1 gene, a kinase target implicated in fibrosis and other diseases. The system, known as Generative Tensorial Reinforcement Learning (GENTRL), designed the new compounds in 21 days, with a lead candidate tested and showing positive results in mice.
Comments »
|